Insider Buying: Fusion Antibodies plc (LON:FAB) Insider Buys £4,500 in Stock

Fusion Antibodies plc (LON:FAB) insider Simon Gordon Douglas bought 150,000 shares of the company’s stock in a transaction on Monday, July 22nd. The stock was purchased at an average price of GBX 3 ($0.04) per share, with a total value of £4,500 ($5,819.97).

Fusion Antibodies Price Performance

Fusion Antibodies stock opened at GBX 3.40 ($0.04) on Thursday. The company has a current ratio of 3.26, a quick ratio of 2.36 and a debt-to-equity ratio of 3.23. The company has a market capitalization of £3.24 million, a PE ratio of -38.67 and a beta of 0.46. Fusion Antibodies plc has a 12 month low of GBX 2.80 ($0.04) and a 12 month high of GBX 9.50 ($0.12). The stock has a 50-day moving average price of GBX 3.35 and a two-hundred day moving average price of GBX 3.85.

About Fusion Antibodies

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.